NCT00791973View on ClinicalTrials.gov

Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen

PHASE4CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

May 31, 2010

Conditions

Allergic Rhinitis

Interventions

DRUG

fluticasone furoate

2 puffs in each nostril once daily for 1 week

DRUG

Placebo

2 puffs in each nostril once daily for 1 week

Trial Locations (1)

60637

University of Chicago Medical Center, Chicago

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Chicago

OTHER